Manufacturer of Controlled Substances; Notice of Application; Siegfried (USA), LLC, 46613 [2013-18338]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 148 / Thursday, August 1, 2013 / Notices
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application;
Siegfried (USA), LLC
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on June 10, 2013,
Siegfried (USA), LLC., 33 Industrial
Park Road, Pennsville, New Jersey
08070, made application by letter to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Drug
Schedule
Opium raw (9600) ........................
Poppy Straw Concentrate (9670)
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substance,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR § 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than September 30, 2013.
Dated: July 23, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–18338 Filed 7–31–13; 8:45 am]
BILLING CODE 4410–09–P
Hampshire (subject firm). The negative
determination was issued on June 14,
2013 and the Department’s Notice of
determination was published in the
Federal Register on July 2, 2013 (78 FR
39774). Workers at the subject firm were
engaged in activities related to the
production of electrical connectors and
backplane assemblies.
The initial investigation resulted in a
negative determination based on the
Department’s findings that sales and
production at the subject firm increased
during that period; that there was no
shift in production to a foreign country
or acquisition of production from a
foreign country; that imports by the
subject firm have decreased; that
Amphenol Backplane Systems, Nashua,
New Hampshire, is neither a Supplier
nor Downstream Producer to a firm that
employed a group of workers who
received a certification of eligibility
under Section 222(a) of the Act, 19
U.S.C. 2272(a); and that the workers’
firm has not been publicly identified by
name by the International Trade
Commission as a member of a domestic
industry in an investigation resulting in
an affirmative finding of serious injury,
market disruption, or material injury, or
threat thereof.
The request for reconsideration
alleges a shift in production/services to
a foreign country, that the subject firm
increased imports, that the subject firm
experienced a loss of business with a
TAA-certified firm, that the subject firm
has factories in Mexico and China.
The Department has carefully
reviewed the request for reconsideration
and the existing record, and will
conduct further investigation to
determine if the workers meet the
eligibility requirements of the Trade Act
of 1974, as amended.
DEPARTMENT OF LABOR
Conclusion
Employment and Training
Administration
After careful review of the
application, I conclude that the claim is
of sufficient weight to justify
reconsideration of the U.S. Department
of Labor’s prior decision. The
application is, therefore, granted.
[TA–W–82,598]
mstockstill on DSK4VPTVN1PROD with NOTICES
Amphenol Backplane Systems,
Nashua, New Hampshire; Notice of
Affirmative Determination Regarding
Application for Reconsideration
By application dated June 24, 2013,
workers requested administrative
reconsideration of the negative
determination regarding workers’
eligibility to apply for Trade Adjustment
Assistance (TAA) applicable to workers
and former workers of Amphenol
Backplane Systems, Nashua, New
VerDate Mar<15>2010
17:02 Jul 31, 2013
Jkt 229001
Signed at Washington, DC, this 22nd day
of July 2013.
Del Min Amy Chen,
Certifying Officer, Office of Trade Adjustment
Assistance.
[FR Doc. 2013–18489 Filed 7–31–13; 8:45 am]
BILLING CODE 4510–FN–P
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
46613
DEPARTMENT OF LABOR
Employment and Training
Administration
[TA–W–82,442]
Deluxe Laboratories, Inc., a Division of
Deluxe Entertainment Services Group,
Inc., Hollywood, California; Notice of
Affirmative Determination Regarding
Application for Reconsideration
By application dated June 20, 2013, a
state workforce official requested
administrative reconsideration of the
negative determination regarding
workers’ eligibility to apply for Trade
Adjustment Assistance (TAA)
applicable to workers and former
workers of Deluxe Laboratories, Inc., a
division of Deluxe Entertainment
Services Group, Inc., Hollywood,
California (subject firm). The negative
determination was issued on May 2,
2013 and the Notice of Determination
was published in the Federal Register
on May 24, 2013 (78 FR 31593–31596).
Workers at the subject firm were
engaged in activities related to the
production of release and trailer prints.
The initial investigation resulted in a
negative determination based on the
Department’s findings that with respect
to Section 222(a)(2)(A)(ii) of the Act,
imports of articles like or directly
competitive with release and trailer
prints have not increased from 2011 to
2012 or from 2012 to 2013 by the
workers’ firm or customers of the
workers’ firm.
With respect to Section 222(a)(2)(B) of
the Act, the investigation revealed that
the workers’ firm did not shift the
production of articles like or directly
competitive with release and trailer
prints to a foreign country or acquire
like or directly competitive articles from
a foreign country during 2011, 2012, or
2013. Rather, the investigation
confirmed that the worker separations
are attributable to decreased demand for
movies and trailers that are printed on
35mm film.
With respect to Section 222(b)(2) of
the Act, the investigation revealed that
Deluxe Laboratories, Inc. is not a
Supplier or Downstream Producer to a
firm that employed a group of workers
who received a certification of eligibility
under Section 222(a) of the Act, 19
U.S.C. 2272(a).
Finally, the group eligibility
requirements under Section 222(e) of
the Act, have not been satisfied because
the workers’ firm has not been publicly
identified by name by the International
Trade Commission as a member of a
domestic industry in an investigation
resulting in an affirmative finding of
E:\FR\FM\01AUN1.SGM
01AUN1
]]>Agencies
[Federal Register Volume 78, Number 148 (Thursday, August 1, 2013)]
[Notices]
[Page 46613]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-18338]
[[Page 46613]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application;
Siegfried (USA), LLC
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on June 10, 2013, Siegfried
(USA), LLC., 33 Industrial Park Road, Pennsville, New Jersey 08070,
made application by letter to the Drug Enforcement Administration (DEA)
to be registered as a bulk manufacturer of the following basic classes
of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Opium raw (9600)........................... II
Poppy Straw Concentrate (9670)............. II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substance, may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR Sec. 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than September 30, 2013.
Dated: July 23, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-18338 Filed 7-31-13; 8:45 am]
BILLING CODE 4410-09-P
